The “Colorectal Cancer Screening Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Colorectal Cancer Screening market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Colorectal Cancer Screening market report also offers market competitors that includes detailed company profiles along with company product specifications.
Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245284
In Colorectal Cancer Screening Market Report, Following Companies Are Covered:
Colorectal Cancer Screening Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.
Scope of the Report:
Reasons for Buying Colorectal Cancer Screening Market Report:
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a five-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245284
Key Market Trends:
Guaiac Fecal Occult Blood Test (gFOBT) is Expected to be the Fastest Growing Segment
The guaiac fecal occult blood test (gFOBT) is one of the several methods that is used to detect colorectal cancer. The test involves the detection of hidden blood in the feces, and identifies the presence of cancer cells or tumours in the colon or rectum. The test involves placing a small sample of stool on specially guaiac coated cards, and then sent to a laboratory for testing. Upon putting a testing solution on the cards, the guaiac causes the stool sample to change colour. The colour changes very quickly if there is blood in the stool. Presence of blood in the stool may be a sign of colorectal cancer or other problems, such as polyps, ulcers, or hemorrhoids. As per the American College of Gastroenterology (ACG), the procedural volumes for colorectal (CRC) screening with gFOBT have decreased modestly. However, the factors that are driving the market are its ease of availability, low cost, and coverage in the insurance, along with being sold as over-the-counter. Also, with product innovation, the method has become reliable. The growth of the market is mainly attributed to the ease of availability and low cost of the products.
North America is Expected to Dominate the Market
According to the United States National Cancer Statistics, colon cancer is reported to be Americas second-deadliest cancer with 50,000 deaths, annually, followed by lung cancer. It was estimated that approximately 1, 44,000 cases of colorectal cancer were found in 2015, and nearly 1, 60, 000 new cases for colorectal cancer are expected to occur by 2020. This increase in the disease occurrence may eventually increase the demand for colorectal cancer screening procedures. Several companies are coming up with advanced screening procedures, including genetic tests, which are gaining acceptability in the US market. According to the National Health Interview Survey, CRC screening (in accordance with guidelines among adults of 50 years and more) increased from 34%, in 2000, to 63%, in 2015. Initiatives, like national TV campaigns, digital marketing, primary care sales force, collated materials, clinical and health publications, etc., are helping increase the adoption of the colorectal cancer screening procedures in the United States. Also, government initiatives are increasing awareness, which is playing an integral role and driving the market for colorectal cancer screening in the country. According to the American Cancer Society, the colon cancer screening rate was 59% in 2010, and increased to 62% in 2015. This rate is increasing at a steady pace, and the goal for colon cancer screening is to reach 80% by 2018. Increasing number of colorectal cancer incidences in the United States, along with several educational and financial initiatives, are expected to increase the colorectal cancer screening market in the United States, in the future.
The Research Document Will Answer Following Questions Such as:
- What are the cutting-edge technologies responsible for driving the growth of the market?
- What are the main applications of the market? What are the growth prospects to the market applications into the market?
- At what stage of development are the key market products?
- What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
- What is the outlook for the industry?
- What difference does performance characteristics of Colorectal Cancer Screening create from those of established entities?
Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14245284
Detailed TOC of Colorectal Cancer Screening Market Report 2019-2024:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advent of Efficacious Genetic Tests
4.2.2 Increase in Prevalence of Colorectal Cancer
4.2.3 Increasing Cancer Prevention Initiatives
4.3 Market Restraints
4.3.1 High Screening Tests Costs
4.3.2 Inadequate Healthcare Access in Developing Countries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Screening Tests
5.1.1 Stool-based Tests
18.104.22.168 Fecal Immunochemical Test (FIT)
22.214.171.124 Guaiac-based Fecal Occult Blood Test (gFOBT)
126.96.36.199 Stool DNA Test
5.1.3 CT Colonography (Virtual Colonoscopy)
5.1.4 Flexible Sigmoidoscopy
5.2 By End User
5.2.2 Independent Diagnostic Labs
5.2.3 Other End Users
5.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.3.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East & Africa
5.3.5 South America
184.108.40.206 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Clinical Genomics Technologies Pty Ltd
6.1.3 Epigenomics Inc.
6.1.4 Exact Sciences Corporation
6.1.5 F. Hoffmann-La Roche AG
6.1.6 Hemosure Inc.
6.1.7 Novigenix SA
6.1.8 Quidel Corporation
6.1.9 Siemens Healthcare Private Limited
6.1.10 Sysmex Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports: